A three-year campaign to raise awareness of stroke will begin in February, using a mixture of advertising, PR and direct …
Abraxis Bioscience has appointed PR agency College Hill to promote its cancer drug Abraxane in Europe. The albumin-bound 'nano-particle' chemotherapeutic …
Cerepro, Ark's gene-based therapy for the brain cancer malignant glioma, has been filed with the European medicines agency. The drug …
Biotech leaders in the UK say the cash-stricken industry has reached 'breaking point', and have made an unprecedented plea for …
Contract research organisation PRA International has opened a new office in Munich, its third base in Germany. Several major pharmaceutical …
The question of ‘generalisability’ – or the extent clinical trials can be applied to the real world, has been an …
Patient: "I've just gone into phase III! What are my chances of coming through alive?" Doctor: "Well the prognosis is …
Cytotoxic therapy has been the cornerstone of cancer treatment for many years: indeed, despite a number of unpleasant side effects, …
The government move to incentivise doctors for the prescription of new innovative medicines has been criticised by the Scottish Medicines …
Prof Sir Michael Rawlins could be set to extend his tenure as chairman of NICE, with the government prepared to …
Hepatitis C patients who don't at first respond to treatment with Pegasys will now be able to receive the drug …
Patients are increasingly holding doctors to account by bringing NICE guidance with them to consultations. Debate at NICE's annual conference …
AstraZeneca's chief executive David Brennan says the pharmaceutical industry could be one of the top performing sectors during the global …
The pharmaceutical industry has hit back at what it says is an ill-informed attack on the sector by the European …
Boehringer Ingelheim's consumer arm has applied to make its urological disorder drug Flomax (tamsulosin) available in the UK from pharmacists …
Cancer death rates in England have dropped and one-year survival rates are up, according to the Department of Health. But …
One of MedImmune's key products has hit a delay in the US, after regulators demanded further data. The FDA asked …
The first of a new generation of primary care centres has been opened in Bradford, which the government hopes will …
When the UK's Olympics team came home from Beijing this summer, laden with a record haul of medals, the nation …